Benzinga | Mar 24, 2021 11:52AM EDT

Noble Capital Markets Initiates Coverage On Helius Medical Tech with Outperform Rating, Announces Price Target of $20

Noble Capital Markets analyst Joe Gomes initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Outperform rating and announces Price Target of $20.